Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Plant One new owner of Bioprocess Pilot Facility at Biotech Campus Delft
Plant One, an established pilot plant company specialized in sustainable production processes, will be the new owner of the Bioprocess Pilot Facility at Biotech Campus Delft. Plant One will further develop the current bioprocess facility into a full-service pilot plant for companies active in biobased and/or biotechnology processes, from SME's to multinationals. The deal was signed at the Biotech Campus Delft earlier today.
Paques Biomaterials | Natural alternatives to plastic
Plastic is everywhere and from its production to its disposal, plastic has a huge impact on our planet. In nature, plastics break down into small particles called microplastics, which accumulate in the food chain. Planet B.io’s resident Paques Biomaterials uses a variety of residual streams to create a biobased and biodegradable alternative to plastic: Caleyda®.
Vivici: Revolutionizing Dairy Protein Production for a Sustainable Future
In a world dealing with the environmental impact of traditional animal agriculture, B2B ingredients company Vivici is dedicated to transforming the landscape of dairy protein production. The Planet B.io resident, driven by a mission for planet-friendly nutrition, uses precision fermentation to create superior dairy proteins, specifically focusing on the whey complex.